Myeloid cells mediate interferon-driven resistance to immunotherapy in advanced renal cell carcinoma
{{output}}
Sustained type-I and type-II interferon (IFN) signaling can drive multiple mechanisms of resistance to immune checkpoint blockade (ICB). Here, we used single-cell RNA sequencing data to characterize the effects of IFNs in the tumor-immune microenvironment (TME... ...
